Overview of NICE’s Elranatamab Managed Ac...

By João L. Carapinha

October 29, 2024

NICE recently recommended Elranatamab as an option for treating relapsed and refractory multiple myeloma in adults with a man...
Rifaximin Use Linked to Daptomycin Resistance: Implications for Antibiotic St...
CTO-PCI Technology for Heart Health in Egypt
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Bupa Launches Whole Genome Sequencing Pilot in UK
Depression and Life Satisfaction in Pregnant Women
Enhancing Child Mental Health Services with Digital Interventions
Created and Validated by FDA: AI Drug Safety Surveillance Tool
The Role of School-Based Health Centres in Advancing Health Equity
Understanding the Impact of COVID-19 on Youth Mental Health
Cost-Effectiveness of Integrated Care for Children with Chronic Conditions
The Impact of Atrial Fibrillation on Quality of Life and Healthcare Costs
Healthy Ageing through Occupational Therapy for Frail Older Adults